Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1093 of 6351
-
Home delivery of addiction meds may keep ex-prisoners clean
Disease control CompletedThis proposed five-year study will focus on whether the addition of providing XR-NTX treatment at a patients' place of residence will increase adherence and thus efficacy of the medication.Following initial screening, informed consent, and medical examination, pre-release prisone…
Phase 3 • Sponsor: Friends Research Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Could Hands-Only CPR be just as good as standard CPR?
Disease control Recruiting nowOut-of-hospital cardiac arrest (OHCA) is one of the leading causes of mortality in the industrialized world. Bystander CPR before arrival of the Emergency Medical Service (EMS) is associated with an increased chance of survival. During the last decade, the best form of bystander…
Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New No-Scalpel heart valve offers hope for leaky hearts
Disease control OngoingThe purpose of this study is to further evaluate the safety and effectiveness of the Harmony™ TPV system. The Pivotal/CAS phases of the study have transitioned into a post-approval study to confirm the long-term functionality of transcatheter implantation of the Medtronic Harmony…
Sponsor: Medtronic Heart Valves • Aim: Disease control
Last updated Jun 26, 2026 18:49 UTC
-
Monthly capsule may keep wheezing away in babies at risk
Prevention CompletedThe primary objective of this study is to evaluate if Broncho-Vaxom® given to high risk infants for 10 days, monthly, for two consecutive years can increase time to occurrence of the first episode of wheezing lower respiratory tract illness (WLRI) during a three year observation …
Phase 2 • Sponsor: University of Arizona • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Simple urine test could spot bladder cancer early, avoiding unnecessary scopes
Diagnosis Recruiting nowTo improve upon the non-invasive detection of BCa by further validating a multiplex ELISA assay directed at a BCa-associated diagnostic signature in voided urine samples of patients with microscopic hematuria.
Sponsor: Cedars-Sinai Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 09:02 UTC
-
Smart pain pump could stop Opioid-Induced breathing trouble
Disease control OngoingThis is a closed-loop system which is embodied in a novel and intelligent algorithm that takes into account patients' vital signs. The system allows better and responsive titration of personalized pain relief together with non-invasive physiological monitoring that measures oxyge…
Phase 2 • Sponsor: KK Women's and Children's Hospital • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Cancer vaccine plus immunotherapy shows promise in Hard-to-Treat cancers
Disease control OngoingThis phase I/II trial studies the best dose and side effects of recombinant human EGF-rP64K/montanide ISA 51 vaccine (CIMAvax) and nivolumab and to see how well they work in treating patients with non-small cell lung cancer or squamous head and neck cancer that has spread to othe…
Phase 1/2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Could a common arthritis drug tame recurring eye inflammation?
Disease control CompletedThe purpose of the study is to demonstrate the effect of Certolizumab Pegol (CZP) treatment on the reduction of Anterior Uveitis (AU) flares in subjects with active axial Spondyloarthritis (axSpA) and a documented history of AU.
Phase 4 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug combo shows promise for Tough-to-Treat hodgkin lymphoma
Disease control OngoingThis phase II trial studies how well ibrutinib and nivolumab work in treating patients with classical Hodgkin lymphoma that has come back or has not responded to treatment. Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoc…
Phase 2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New combo therapy shows promise in controlling advanced liver cancer
Disease control CompletedThe purpose of this study is to evaluate the effect of liver-localised radioembolization and nivolumab on liver cancer.
Phase 2 • Sponsor: National Cancer Centre, Singapore • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New combo therapy shows promise for lung cancer brain metastases
Disease control OngoingThis phase I/II trial studies the side effects and best dose of nivolumab when giving together with stereotactic radiosurgery or whole brain radiotherapy with or without ipilimumab and to see how well they work in treating patients with non-small cell lung cancer that has spread …
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Hope for ataxia: experimental drug shows promise in Late-Stage trial
Disease control CompletedThe primary purpose of this study was to compare the efficacy of BHV-4157 (Troriluzole) 140 milligrams (mg) once daily versus placebo after 8 weeks of treatment in participants with spinocerebellar ataxia (SCA).
Phase 2/3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New combo attack on tough pancreatic cancer shows promise in early trial
Disease control CompletedThis is a phase 1 (the first phase in testing a new drug, to see how safe a new drug or new indication/population ) and phase 2 (the second phase in testing a new drug or new indication/population to see how effective the drug is) study of neoadjuvant (treatment before the main t…
Phase 1/2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can a pill that starves tumors of oxygen help fight advanced cancer?
Disease control OngoingThe primary objective of this study is to identify the maximum tolerated dose (MTD) of belzutifan Tablets and/or the recommended Phase 2 dose (RP2D) of belzutifan Tablets in patients with advanced solid tumors
Phase 1 • Sponsor: Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can meditation rewire the anxious social brain?
Symptom relief CompletedThe purpose of this study is to develop and test a mindfulness and loving-kindness based intervention, Positive Affect Training (PAT), to enhance positive affect such as compassion, love, and gratitude and reduce symptoms of social anxiety disorder (SAD). PAT involves a combinati…
Sponsor: Komazawa University • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
New chemo cocktail shows promise for rare bone cancer
Disease control CompletedEwing's sarcoma and related tumours (ESFT) are rare tumours, with a peak incidence in the second decade of life. They start most often from bone, and are characterized by a specific translocation involving the so-called EWS gene. In one patient out of three, the staging procedure…
Phase 2 • Sponsor: Institut Curie • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Radioactive 'Smart Bomb' targets Hard-to-Treat prostate cancer
Disease control OngoingThe purpose of this study is to find the highest dose level of the study drug, 177Lu-PSMA-617 that can be given without severe side effects for advanced prostate cancer.
Phase 1/2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 26, 2026 18:06 UTC
-
Can adding radiation before surgery help stomach cancer patients live longer?
Disease control CompletedAlthough the incidence of gastric cancer has been substantially declining for several decades, it is still the sixth most common cancer and the fourth most frequent cause of cancer death worldwide. Surgery is still the only curative option for gastric cancer. However, most patien…
Phase 3 • Sponsor: Shanghai Cancer Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Which blood thinner works best after joint surgery? huge study reveals answers
Prevention CompletedPEPPER is a randomized study comparing the three most commonly used anticoagulants in North America in patients who have elected to undergo primary or revision hip or knee joint replacement surgery. The anticoagulants being compared are enteric coated aspirin, low intensity warfa…
Phase 4 • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Prevention
Last updated Jun 27, 2026 12:06 UTC
-
Could a diabetes drug help leukemia patients stay off cancer pills?
Disease control Recruiting nowSingle-center study, prospective, phase II trial. The study objectives are : * To assess safety and pharmacokinetics of the combination of PIO and TKI in CML subjects who experience a loss of MMR following a first TKI discontinuation. * To assess survival without loss of MMR ov…
Phase 2 • Sponsor: Versailles Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC